One of the key challenges that companies hoping to launch or scale a Connected Health product face is the requirement to show how their product or service can add-value to the care pathway – in terms of cost-effectiveness and in terms of improvements in care outcomes. In order to tackle the issue of cost-effectiveness, ARCH has applied innovative healthcare costing methodologies to map and cost the care pathways for a selection of chronic diseases, including dementia and heart-failure.

Executive Summaries

Full Executive Summary available here
Full Executive Summary available here